Investor Resources
CSE: PMED
OTC MARKETS: PMEDF
About Predictmedix
Predictmedix is a Life Sciences technology company developing AI-powered products to improve workplace health and safety, enhance protection in public environments, and provide tools for medical professionals to better care for patients.
Our Team
Dr. Rahul Kushwah
Interim CEO, Director
PhD, Banting Fellow. Developed world’s first genetic test for cannabis pharmacogenetics. Previously on the National Research Council for the Government of Canada in Human Health Therapeutics. Expertise in human diseases, genetics, immunology and regenerative/personalized
Sheldon Kales
Director
Expertise in operations, business strategy and capital markets. Held leadership roles operating R&D companies in the USA, Canada and the Middle East. Led companies from start-up stages through growth and successful
Kapil Raval
Advisory Board Chair, Director of AI, Business Development, Microsoft
Global Business Leader with 25+ years experience. Kapil is currently a director at Microsoft, driving business development for AI solutions for different industries globally. Having worked for global organizations like Philips, DEC, Compaq and HPE & Microsoft in Americas, Middle East and APJ, Kapil brings understanding of global cultural & market nuances, inventiveness & problem-solving
Nandan Mishra
Co-AI Lead
Artificial Intelligence pioneer in translational research for AI. Masters in Systems Biology and Bachelors Degree in Engineering from the Indian Institute of Technology. Member of the prestigious National Mission of Interdisciplinary Cyber Physical Systems of India (a federal technology think
Rajiv Muradia
VP of Technology
Mobilewellbeing Founder. Executive entrepreneur with experience in technology, management and business development. Successfully founded several companies and has helped a number of start-ups with their product strategy, positioning and technology
Tomas Sipos
Director
Seasoned investment banker. Has held several senior positions, including VP, Mergers and Acquisitions of Ernst & Young, Managing Director of Investment Banking at European Privatization & Investment Corporation and Senior Investment Banker for the International Finance Corporation. Presently, CFO for Pistil Partners Inc., and serves as a director of NATO Association of Canada Program
Himanshu Ujjawal Singh
Co-AI Lead
Specialization in Data Analytics and AI. Consulted with several multinational corporations in setting up their analytics practice in the field of telecom, healthcare, retail and workforce analytics. Expertise in data
Praveen Kumar
Data Analytics Lead
Specialization in Data Analytics, Machine Learning and Deep Neural Networks. Worked with several top Fortune 500 companies. Consulted with top financial corporations in
Ajit Kumar
Director
Seasoned healthcare business leader. Founder of K-Med Ltd.; among the largest suppliers of healthcare and medical equipment in the UK with operations in the Middle East, EU and
Dr. Mike Hart
Advisor
Dr. Mike Hart is well-known for his outspoken advocacy for medicinal cannabis, with both a medical degree from the Saba School of Medicine in the Netherlands Antilles (2010) and a family medicine residency from Western University (2012). He founded the first physician-led Cannabis Clinic in London
Dr. Alexander D. Bardon
CCCP (EM) Emergency Room physician for over 6 years. Expertise in infectious disease and screening. Works in 3 different hospital emergency departments: Norfolk General, St. Mary’s General and Grand River Hospital § Associate Clinical Professor at McMaster
Guru Seghal
Managing Director for India Operations
Recent Press
Predictmedix and Partners Launch Safe Entry Station as a Comprehensive Fit for Duty Screening Solution at Electra Mining Africa and National Safety Council’s (NSC) Congress & Expo
Toronto, ON, August 8, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that its Safe Entry Station will be used as a comprehensive Fit for Duty screening solution for workplaces and industries around the world, detecting […]
Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters
Toronto, ON, July 25, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced its accuracy rates for identifying Respiration Rate, Heart Rate, and Core Body Temperature as part of its Fit for Work screening solutions for industries […]
Predictmedix Receives $1.85 Million Letter of Intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies
Toronto, ON, June 29, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that it has received a non-binding Letter of Intent (LOI) from KaTron Defence Space and Simulation Technologies, a leading Turkish provider of simulation products […]
